Xcout Intel
Astromech AI Corp.
Astromech AI Corp. is developing an autonomous biological intelligence system, termed the Large Life Model, which integrates deep learning with evolutionary biology. The platform is designed to process multi-species transcriptomic and genomic data to assist researchers in therapeutic development, trait optimization, and systems biology.
Subscribe to see Astromech AI Corp.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Astromech AI Corp. at a glance
Astromech AI Corp. is an artificial intelligence & biotechnology company headquartered in United States. Its most recent funding round raised $20M in August 2026. Xcout tracks 5 named people at Astromech AI Corp., including Brian Beard (Chief Legal Officer).
Astromech AI Corp. leadership
- Brian BeardChief Legal Officer
- Benjamin LammCo-Founder, CEO and Director
- George ChurchPromoter
- Benjamin LammExecutive Officer
- Brian BeardExecutive Officer
Astromech AI Corp. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $20M | 4 named | |
| SEC Form D filing | $10.5M | — | |
| SEC Form D filing | $30M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Astromech AI Corp. competitors
A few of Astromech AI Corp.'s closest competitors — see the full list of competitors and alternatives →
Latent Labs Technologies operates as a frontier artificial intelligence laboratory that builds generative models for molecular biology. The company provides AI-driven tools and agents—such as Latent-Y, Latent-X2, and Latent-X—to help researchers and partners design drugs, create antibodies, optimize enzymes, and advance genetic engineering.
AI Vivo is an early-stage biotechnology research startup headquartered in Cambridge, England. The company specializes in designing artificial intelligence systems and utilizing multi-modal omics data to map organ-level disease biology.
Syntekabio Inc. is a South Korean bioinformatics venture firm founded in 2009. The company operates as an artificial intelligence new drug development company, utilizing genomic big data.
Ataraxis AI is an artificial intelligence company headquartered in New York that links AI model predictions to real patient outcomes across oncology.
BIO-AI, Inc. develops AI-driven world models to simulate human biology across multiple scales. The company builds programmable virtual cells and a general-purpose cell biology simulator to accelerate research and discovery for medicine, biotechnology, and life sciences.
Pepticom operates an artificial intelligence-driven drug discovery platform focused on designing and optimizing novel therapeutic peptides. The company utilizes reinforcement learning, generative AI, and computational algorithms to develop drug candidates for both internal programs and industry collaborations.
Get Astromech AI Corp.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Astromech AI Corp.? Suggest a correction · Work at Astromech AI Corp.? Claim this profile
Is this your company? Add the Xcout Intel badge to your website
Free, for any company on Xcout Intel. It links visitors to this profile.
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Astromech AI Corp. in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access